Structures by: Królewska-Golińska K.
Total: 6
(Ru3),(SN3C12H11),(PC18H15),3(Cl1)
(Ru3),(SN3C12H11),(PC18H15),3(Cl1)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10689-10702
a=8.5500(9)Å b=10.1649(11)Å c=17.925(2)Å
α=92.169(10)° β=97.822(10)° γ=99.235(9)°
(Ru3),3(Cl1),(PC18H15),(SN3C12H11)
(Ru3),3(Cl1),(PC18H15),(SN3C12H11)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10689-10702
a=10.6546(3)Å b=17.3387(4)Å c=15.9083(4)Å
α=90° β=97.968(2)° γ=90°
(Ru3),(Cl1)3,(PC18H15),(SN3C12H11),(C2H6O)
(Ru3),(Cl1)3,(PC18H15),(SN3C12H11),(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10689-10702
a=10.0260(10)Å b=11.6073(13)Å c=15.3369(12)Å
α=80.329(8)° β=88.746(7)° γ=65.886(10)°
Ethyl 4-[(4-chlorobenzyl)sulfanyl]-6-methyl-2-phenylpyrimidine-5-carboxylate
C21H19ClN2O2S
Acta Crystallographica Section C (2018) 74, 10 1138-1145
a=7.8332(18)Å b=10.401(2)Å c=12.166(3)Å
α=76.05(2)° β=84.86(2)° γ=79.63(2)°
4-[(4-Chlorobenzyl)sulfanyl]-5,6-dimethyl-2-phenylpyrimidine
C19H17ClN2S
Acta Crystallographica Section C (2018) 74, 10 1138-1145
a=14.4729(8)Å b=11.4849(5)Å c=10.3302(6)Å
α=90° β=104.605(5)° γ=90°
{4-[(4-Chlorobenzyl)sulfanyl]-6-methyl-2-phenylpyrimidin-5-yl}methanol
C19H17ClN2OS
Acta Crystallographica Section C (2018) 74, 10 1138-1145
a=4.6074(12)Å b=22.882(8)Å c=31.816(12)Å
α=90° β=92.41(5)° γ=90°